查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1933359

全球標準胰島素筆針市場：市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的考量、未來預測（2026-2034）

Standard Pen Needles Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 130 Pages | 商品交期: 請詢問到貨日

價格

標準胰島素筆針市場成長因素

預計2025年全球標準胰島素筆針市場規模將達到16.5億美元，2026年將成長至17.4億美元，到2034年將達到30.7億美元，預測期內複合年增長率（CAGR）為7.31%。北美地區將引領市場，2025年將佔66%的市場佔有率，這主要得益於該地區糖尿病的高發生率、完善的胰島素注射基礎設施以及胰島素筆作為傳統注射器的廣泛應用。標準胰島素筆針是一種與胰島素筆和其他注射藥物配合使用的醫療器械，可實現皮下注射。它們能夠實現無痛、精準、便捷的自我注射，因此在糖尿病管理中尤其重要。 諾和諾德 (Novo Nordisk A/S)、BD 和 Embector 等主要市場參與者正專注於技術創新、策略聯盟和大規模投資，以保持其市場領先地位。

市場動態

驅動因素：全球糖尿病盛行率的不斷上升是推動市場發展的關鍵因素。根據國際糖尿病聯盟 (IDF) 2023 年的數據，超過 5.3 億成年人患有糖尿病，預計未來幾十年這一數字將繼續增長。胰島素筆因其便攜性和易用性而受到老年人和視力障礙患者的青睞，其日益普及也推動了市場發展。政府和非政府組織為改善胰島素和胰島素筆針的可及性而採取的舉措，以及進行的糖尿病管理宣傳活動，也促進了市場成長。 例如，2024年8月，Breakthrough T1D發起了 "檢測，才能做決定" 活動，旨在促進第1型糖尿病的早期發現。

限制因素：針頭恐懼症、注射方案依從性差以及胰島素筆針頭的重複使用阻礙了市場成長。在全球範圍內，28%的糖尿病患者表示害怕針頭，導致漏服藥物和血糖控制不佳。認知度低和缺乏強有力的報銷政策，尤其是在新興市場，限制了胰島素筆針頭的進一步普及。

機會：在亞洲、拉丁美洲和非洲的中等收入國家擴大市場准入提供了巨大的機會。這些地區糖尿病盛行率的上升、城市化進程以及醫療基礎設施的改善，正在推動對經濟實惠、易於使用的胰島素筆針頭的需求。 2025年6月，無國界醫生組織（MSF）對諾和諾德承諾以每支1美元的價格向南非供應胰島素筆表示歡迎，這標誌著改善胰島素筆可及性的努力正在不斷擴大。

挑戰：新興市場自動注射器和其他先進給藥系統的普及率仍然較低，這仍然是一個挑戰。在中國和印度等國家，高昂的成本和缺乏報銷政策阻礙了這些新型設備的普及。

市場趨勢

技術創新正在重塑市場。製造商正在開發超細、短針頭的注射筆，並採用先進的潤滑和安全設計，以減輕疼痛和焦慮。可伸縮或有防護罩的針頭提高了護理人員的安全性。能夠記錄和傳輸胰島素劑量的智慧注射筆越來越受歡迎，以提高用藥依從性和疾病管理。例如，2022年9月，泰爾茂株式會社在印度推出了 "FineGlide" 無菌注射筆針頭，強調病患的舒適度和與自我注射療法的兼容性。

市場區隔分析

依藥物類型劃分：2024年，胰島素類藥物佔市場主導地位，主要得益於第1型糖尿病和晚期第2型糖尿病的長期治療需求。 GLP-1類藥物則位居第二，主要得益於處方量的成長和核准藥物的擴大（例如，Biocon Limited於2025年2月在英國推出利拉魯肽，用於治療肥胖症和糖尿病）。

依疾病區分：糖尿病是推動市場成長的主要因素，這主要歸功於注射療法的廣泛需求。肥胖症市場預計將快速成長，這主要得益於全球肥胖症盛行率的上升以及相應注射療法的廣泛應用。

依針頭尺寸劃分：2024年，4毫米針頭佔主導地位，這主要歸功於其舒適性、降低肌肉注射風險以及醫生的偏好。 6毫米針頭市場預計將會成長，這主要得益於高BMI成人和肥胖患者的使用量增加。

依分銷管道劃分：由於便利性和可及性，零售藥局在2024年佔了最大的市場佔有率，但由於送貨上門服務、訂閱模式和數位醫療的擴展，預計線上藥局將成長最快。

區域展望

北美：由於糖尿病的高發生率和成熟的胰島素輸注系統，預計2025年市場規模將達到6.3億美元。強而有力的報銷政策促使注射筆在美國廣泛應用，而加拿大家庭醫療保健機構的使用率也不斷提高。

歐洲：在自我注射療法意識不斷提高和有利的醫療保健政策的支持下，歐洲正在佔相當大的市場佔有率。 2024年，英國開出了7,100萬張糖尿病管理處方。

亞太地區：由於糖尿病患者人數的增加、城市化進程的加速以及醫療保健服務的改善，預計該地區將實現最高的成長率。 監管部門的批准，例如諾和諾德的諾和銳在中國獲批（2022年），正在推動市場擴張。

拉丁美洲、中東和非洲：預計將保持穩定成長。巴西、墨西哥、沙烏地阿拉伯和阿拉伯聯合大公國等國家正面臨糖尿病盛行率上升、政府措施增加以及醫療基礎設施不斷完善等議題。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：關鍵考慮因素

  • 主要公司新產品發布
  • 主要產業趨勢：併購、業務合作等
  • 生物製藥製造技術進步

第五章：全球標準注射筆針市場分析：洞察與預測（2021-2034）

  • 市場分析、洞察與預測：依藥物類型劃分
    • 胰島素
    • GLP-1
    • 生長激素
    • 其他
  • 市場分析、洞察與預測：依疾病劃分
    • 糖尿病
    • 肥胖症
    • 荷爾蒙缺乏症
    • 其他
  • 市場分析、洞察與預測：依針頭尺寸劃分
    • 4毫米
    • 5毫米
    • 6毫米
    • 8毫米
    • 12毫米
  • 市場分析、洞察與預測：依通路劃分
    • 醫院藥房
    • 零售藥房
    • 線上藥房
  • 市場分析，洞察與預測：依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章：北美標準注射筆針市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第七章：歐洲標準注射筆針市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪的納維亞
    • 歐洲其他地區

章節第八章：亞太地區標準注射筆針市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 東南亞
    • 亞太其他地區

第九章：拉丁美洲標準注射筆針市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第十章：中東與非洲標準注射筆針市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 海灣合作委員會（海灣合作委員會）國家
    • 南非
    • 其他中東和非洲國家

第十一章：競爭分析

  • 全球市佔率分析（2025 年）
  • 公司簡介
  • Embecta Corp.
  • Cardinal Health
  • MTD Medical Technology and Devices
  • UltiMed, Inc.
  • Allison Medical, Inc.
  • Owen Mumford
  • Medline Industries, LP
  • B. Braun SE
  • Neon Diagnostics Limited
  • Other Prominent Players
Product Code: FBI113830

Growth Factors of standard pen needles Market

The global standard pen needles market was valued at USD 1.65 billion in 2025 and is projected to grow to USD 1.74 billion in 2026, reaching USD 3.07 billion by 2034, at a CAGR of 7.31% during the forecast period. North America dominated the market in 2025 with a 66% share, supported by high diabetes prevalence, well-established insulin delivery infrastructure, and widespread adoption of insulin pens over traditional syringes. Standard pen needles are medical devices used with insulin pens and other injectable medications for subcutaneous delivery, offering painless, precise, and convenient self-administration, which is particularly beneficial in diabetes management. Key market players, including Novo Nordisk A/S, BD, and Embecta Corp., are focusing on technological innovations, strategic collaborations, and extensive investments to maintain market leadership.

Market Dynamics

Drivers: The rising global prevalence of diabetes is the primary driver for the market. According to the International Diabetes Federation (IDF) 2023, over 530 million adults were living with diabetes, with numbers expected to rise in the coming decades. The growing adoption of insulin pens, favored for their portability and ease of use, especially among elderly and visually impaired patients, further drives the market. Initiatives by governments and NGOs to improve access to insulin and pen needles, along with campaigns to raise awareness about diabetes management, also contribute to market growth. For example, in August 2024, Breakthrough T1D launched the campaign "Detect so you can decide" to promote early Type 1 diabetes detection.

Restraints: Needle phobia, poor compliance with injection protocols, and reuse of pen needles hamper market growth. Globally, 28% of diabetic patients reportedly suffer from needle phobia, leading to skipped doses and poor glycemic control. Limited awareness and lack of strong reimbursement policies, especially in emerging markets, further restrict adoption.

Opportunities: Expanding market access in middle-income countries across Asia, Latin America, and Africa provides a significant opportunity. Rising diabetes prevalence, urbanization, and improved healthcare infrastructure in these regions drive demand for cost-effective and user-friendly pen needles. In June 2025, Medecins Sans Frontieres (MSF) welcomed Novo Nordisk's initiative to supply insulin pens to South Africa at USD 1 per pen, reflecting growing accessibility efforts.

Challenges: Limited penetration of autoinjectors and other advanced drug delivery systems in emerging markets remains a challenge. Higher costs and lack of reimbursement policies in countries like China and India reduce adoption of these novel devices.

Market Trends

Technological innovations are reshaping the market. Manufacturers are developing ultra-fine, short-length pen needles with advanced lubrication and safety-engineered designs to reduce pain and anxiety. Devices with retractable or shielded needles enhance caregiver safety. Smart pens with digital integration, capable of recording and transmitting insulin doses, are gaining popularity to improve adherence and disease management. For instance, in September 2022, Terumo Corporation launched the FineGlide sterile pen needle in India, emphasizing patient comfort and compatibility with self-administered insulin therapy.

Segmentation Analysis

By Drug Type: The insulin segment dominated in 2024, driven by long-term therapy for Type 1 and advanced Type 2 diabetes. The GLP-1 segment held the second-largest share, with growth supported by rising prescriptions and approvals, such as Biocon Limited's Liraglutide launch in February 2025 for obesity and diabetes treatment in the U.K.

By Disease Indication: Diabetes leads the market due to widespread injectable therapy requirements. The obesity segment is expected to grow rapidly with increasing global prevalence and adoption of compatible injectable therapies.

By Needle Size: The 4 mm needle dominated in 2024 due to comfort, reduced risk of intramuscular injection, and physician preference. The 6 mm needle segment is projected to grow, driven by use in adults with higher BMI or obesity.

By Distribution Channel: Retail pharmacies held the largest market share in 2024, offering convenience and accessibility, while online pharmacies are expected to grow fastest due to home delivery, subscription models, and digital health expansion.

Regional Outlook

North America: Market size reached USD 0.63 billion in 2025, driven by high diabetes prevalence and well-established insulin delivery systems. In the U.S., pen injectors benefit from strong reimbursement policies, while Canada is seeing rising adoption in home care.

Europe: Holds a significant share, supported by increasing awareness of self-injection therapies and favorable healthcare policies. In the U.K., 71 million items were prescribed for diabetes management in 2024.

Asia Pacific: Expected to grow at the fastest rate due to rising diabetes, urbanization, and healthcare access improvements. Regulatory approvals, such as Novo Nordisk's Novopen in China (2022), drive market expansion.

Latin America & Middle East & Africa: Steady growth is anticipated. Countries like Brazil, Mexico, Saudi Arabia, and UAE are witnessing rising diabetes prevalence, government-led initiatives, and expanding healthcare infrastructure.

Competitive Landscape

The market is fragmented, with key players including Embecta Corp., Cardinal Health, MTD Medical Technology and Devices, UltiMed, Inc., Owen Mumford, Medline Industries, and Braun SE. Strategic partnerships, acquisitions, and new product launches are common strategies. Key developments include Braun SE's collaboration with Orlando Health in March 2025 and Owen Mumford's partnership with Duopharma Biotech in February 2024.

Conclusion

The global standard pen needles market is projected to grow from USD 1.65 billion in 2025 to USD 1.74 billion in 2026, reaching USD 3.07 billion by 2034. Market growth is driven by rising diabetes prevalence, increasing insulin pen adoption, and technological advancements enhancing patient comfort. While needle phobia and limited penetration of autoinjectors present challenges, expansion in emerging markets and digital integration offer significant opportunities through 2034.

Segmentation By Drug Type, Disease Indication, Needle Size, Distribution Channel, and Region

By Drug Type * Insulin

  • GLP-1
  • Growth Hormone
  • Others

By Disease Indication * Diabetes

  • Obesity
  • Hormone Deficiency
  • Others

By Needle Size * 4 mm

  • 5 mm
  • 6 mm
  • 8 mm
  • 12 mm

By Distribution Channel * Hospital Pharmacy

  • Retail Pharmacy
  • Online Pharmacy

By Region * North America (By Drug Type, Disease Indication, Needle Size, Distribution Channel, and Country)

    • U.S.
    • Canada
  • Europe (By Drug Type, Disease Indication, Needle Size, Distribution Channel, and Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific (By Drug Type, Disease Indication, Needle Size, Distribution Channel, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America (By Drug Type, Disease Indication, Needle Size, Distribution Channel, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Drug Type, Disease Indication, Needle Size, Distribution Channel, and Country/Sub-region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. New Product Launches, By Key Players
  • 4.2. Key Industry Developments (Mergers, Acquisitions, Partnerships, and Others)
  • 4.3. Technological Advancements in Biopharmaceutical Processing

5. Global Standard Pen Needles Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Drug Type
    • 5.1.1. Insulin
    • 5.1.2. GLP-1
    • 5.1.3. Growth Hormone
    • 5.1.4. Others
  • 5.2. Market Analysis, Insights and Forecast - By Disease Indication
    • 5.2.1. Diabetes
    • 5.2.2. Obesity
    • 5.2.3. Hormone Deficiency
    • 5.2.4. Others
  • 5.3. Market Analysis, Insights and Forecast - By Needle Size
    • 5.3.1. 4 mm
    • 5.3.2. 5 mm
    • 5.3.3. 6 mm
    • 5.3.4. 8 mm
    • 5.3.5. 12 mm
  • 5.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 5.4.1. Hospital Pharmacy
    • 5.4.2. Retail Pharmacy
    • 5.4.3. Online Pharmacy
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Standard Pen Needles Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Drug Type
    • 6.1.1. Insulin
    • 6.1.2. GLP-1
    • 6.1.3. Growth Hormone
    • 6.1.4. Others
  • 6.2. Market Analysis, Insights and Forecast - By Disease Indication
    • 6.2.1. Diabetes
    • 6.2.2. Obesity
    • 6.2.3. Hormone Deficiency
    • 6.2.4. Others
  • 6.3. Market Analysis, Insights and Forecast - By Needle Size
    • 6.3.1. 4 mm
    • 6.3.2. 5 mm
    • 6.3.3. 6 mm
    • 6.3.4. 8 mm
    • 6.3.5. 12 mm
  • 6.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 6.4.1. Hospital Pharmacy
    • 6.4.2. Retail Pharmacy
    • 6.4.3. Online Pharmacy
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Standard Pen Needles Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Drug Type
    • 7.1.1. Insulin
    • 7.1.2. GLP-1
    • 7.1.3. Growth Hormone
    • 7.1.4. Others
  • 7.2. Market Analysis, Insights and Forecast - By Disease Indication
    • 7.2.1. Diabetes
    • 7.2.2. Obesity
    • 7.2.3. Hormone Deficiency
    • 7.2.4. Others
  • 7.3. Market Analysis, Insights and Forecast - By Needle Size
    • 7.3.1. 4 mm
    • 7.3.2. 5 mm
    • 7.3.3. 6 mm
    • 7.3.4. 8 mm
    • 7.3.5. 12 mm
  • 7.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 7.4.1. Hospital Pharmacy
    • 7.4.2. Retail Pharmacy
    • 7.4.3. Online Pharmacy
  • 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.5.1. U.K.
    • 7.5.2. Germany
    • 7.5.3. France
    • 7.5.4. Spain
    • 7.5.5. Italy
    • 7.5.6. Scandinavia
    • 7.5.7. Rest of Europe

8. Asia pacific Standard Pen Needles Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Drug Type
    • 8.1.1. Insulin
    • 8.1.2. GLP-1
    • 8.1.3. Growth Hormone
    • 8.1.4. Others
  • 8.2. Market Analysis, Insights and Forecast - By Disease Indication
    • 8.2.1. Diabetes
    • 8.2.2. Obesity
    • 8.2.3. Hormone Deficiency
    • 8.2.4. Others
  • 8.3. Market Analysis, Insights and Forecast - By Needle Size
    • 8.3.1. 4 mm
    • 8.3.2. 5 mm
    • 8.3.3. 6 mm
    • 8.3.4. 8 mm
    • 8.3.5. 12 mm
  • 8.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 8.4.1. Hospital Pharmacy
    • 8.4.2. Retail Pharmacy
    • 8.4.3. Online Pharmacy
  • 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.5.1. Japan
    • 8.5.2. China
    • 8.5.3. India
    • 8.5.4. Australia
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of Asia Pacific

9. Latin America Standard Pen Needles Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Drug Type
    • 9.1.1. Insulin
    • 9.1.2. GLP-1
    • 9.1.3. Growth Hormone
    • 9.1.4. Others
  • 9.2. Market Analysis, Insights and Forecast - By Disease Indication
    • 9.2.1. Diabetes
    • 9.2.2. Obesity
    • 9.2.3. Hormone Deficiency
    • 9.2.4. Others
  • 9.3. Market Analysis, Insights and Forecast - By Needle Size
    • 9.3.1. 4 mm
    • 9.3.2. 5 mm
    • 9.3.3. 6 mm
    • 9.3.4. 8 mm
    • 9.3.5. 12 mm
  • 9.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 9.4.1. Hospital Pharmacy
    • 9.4.2. Retail Pharmacy
    • 9.4.3. Online Pharmacy
  • 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle East & Africa Standard Pen Needles Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Drug Type
    • 10.1.1. Insulin
    • 10.1.2. GLP-1
    • 10.1.3. Growth Hormone
    • 10.1.4. Others
  • 10.2. Market Analysis, Insights and Forecast - By Disease Indication
    • 10.2.1. Diabetes
    • 10.2.2. Obesity
    • 10.2.3. Hormone Deficiency
    • 10.2.4. Others
  • 10.3. Market Analysis, Insights and Forecast - By Needle Size
    • 10.3.1. 4 mm
    • 10.3.2. 5 mm
    • 10.3.3. 6 mm
    • 10.3.4. 8 mm
    • 10.3.5. 12 mm
  • 10.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 10.4.1. Hospital Pharmacy
    • 10.4.2. Retail Pharmacy
    • 10.4.3. Online Pharmacy
  • 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.5.1. GCC
    • 10.5.2. South Africa
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
    • 11.2.1. Embecta Corp.
    • 11.2.2. Cardinal Health
    • 11.2.3. MTD Medical Technology and Devices
    • 11.2.4. UltiMed, Inc.
    • 11.2.5. Allison Medical, Inc.
    • 11.2.6. Owen Mumford
    • 11.2.7. Medline Industries, LP
    • 11.2.8. B. Braun SE
    • 11.2.9. Neon Diagnostics Limited
    • 11.2.10. Other Prominent Players

List of Tables

  • Table 1: Global Standard Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 2: Global Standard Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2021-2034
  • Table 3: Global Standard Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2021-2034
  • Table 4: Global Standard Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 5: Global Standard Pen Needles Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 6: North America Standard Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 7: North America Standard Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2021-2034
  • Table 8: North America Standard Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2021-2034
  • Table 9: North America Standard Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 10: North America Standard Pen Needles Market Revenue (USD billion) Forecast, by Country, 2021-2034
  • Table 11: Europe Standard Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 12: Europe Standard Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2021-2034
  • Table 13: Europe Standard Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2021-2034
  • Table 14: Europe Standard Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 15: Europe Standard Pen Needles Market Revenue (USD billion) Forecast, by Country/Sub-Region, 2021-2034
  • Table 16: Asia Pacific Standard Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 17: Asia Pacific Standard Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2021-2034
  • Table 18: Asia Pacific Standard Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2021-2034
  • Table 19: Asia Pacific Standard Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 20: Asia Pacific Standard Pen Needles Market Revenue (USD billion) Forecast, by Country/Sub-Region, 2021-2034
  • Table 21: Latin America Standard Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 22: Latin America Standard Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2021-2034
  • Table 23: Latin America Standard Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2021-2034
  • Table 24: Latin America Standard Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 25: Latin America Standard Pen Needles Market Revenue (USD billion) Forecast, by Country/Sub-Region, 2021-2034
  • Table 26: Middle East & Africa Standard Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2021-2034
  • Table 27: Middle East & Africa Standard Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2021-2034
  • Table 28: Middle East & Africa Standard Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2021-2034
  • Table 29: Middle East & Africa Standard Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 30: Middle East & Africa Standard Pen Needles Market Revenue (USD billion) Forecast, by Country/Sub-Region, 2021-2034

List of Figures

  • Figure 1: Global Standard Pen Needles Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Standard Pen Needles Market Value Share (%), by Drug Type, 2025 & 2034
  • Figure 3: Global Standard Pen Needles Market Value Share (%), by Disease Indication, 2025 & 2034
  • Figure 4: Global Standard Pen Needles Market Value Share (%), by Needle Size, 2025 & 2034
  • Figure 5: Global Standard Pen Needles Market Value Share (%), by Distribution Channel, 2025 & 2034
  • Figure 6: Global Standard Pen Needles Market Value (USD billion), by Region, 2025 & 2034
  • Figure 7: North America Standard Pen Needles Market Value (USD billion), by Drug Type, 2025 & 2034
  • Figure 8: North America Standard Pen Needles Market Value Share (%), by Drug Type, 2025
  • Figure 9: North America Standard Pen Needles Market Value (USD billion), by Disease Indication, 2025 & 2034
  • Figure 10: North America Standard Pen Needles Market Value Share (%), by Disease Indication, 2025
  • Figure 11: North America Standard Pen Needles Market Value (USD billion), by Needle Size, 2025 & 2034
  • Figure 12: North America Standard Pen Needles Market Value Share (%), by Needle Size, 2025
  • Figure 13: North America Standard Pen Needles Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 14: North America Standard Pen Needles Market Value Share (%), by Distribution Channel, 2025
  • Figure 15: North America Standard Pen Needles Market Value (USD billion), By Country, 2025 & 2034
  • Figure 16: North America Standard Pen Needles Market Value Share (%), By Country, 2025
  • Figure 17: Europe Standard Pen Needles Market Value (USD billion), by Drug Type, 2025 & 2034
  • Figure 18: Europe Standard Pen Needles Market Value Share (%), by Drug Type, 2025
  • Figure 19: Europe Standard Pen Needles Market Value (USD billion), by Disease Indication, 2025 & 2034
  • Figure 20: Europe Standard Pen Needles Market Value Share (%), by Disease Indication, 2025
  • Figure 21: Europe Standard Pen Needles Market Value (USD billion), by Needle Size, 2025 & 2034
  • Figure 22: Europe Standard Pen Needles Market Value Share (%), by Needle Size, 2025
  • Figure 23: Europe Standard Pen Needles Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 24: Europe Standard Pen Needles Market Value Share (%), by Distribution Channel, 2025
  • Figure 25: Europe Standard Pen Needles Market Value (USD billion), By Country/Sub-region, 2025 & 2034
  • Figure 26: Europe Standard Pen Needles Market Value Share (%), By Country/Sub-region, 2025
  • Figure 27: Asia Pacific Standard Pen Needles Market Value (USD billion), by Drug Type, 2025 & 2034
  • Figure 28: Asia Pacific Standard Pen Needles Market Value Share (%), by Drug Type, 2025
  • Figure 29: Asia Pacific Standard Pen Needles Market Value (USD billion), by Disease Indication, 2025 & 2034
  • Figure 30: Asia Pacific Standard Pen Needles Market Value Share (%), by Disease Indication, 2025
  • Figure 31: Asia Pacific Standard Pen Needles Market Value (USD billion), by Needle Size, 2025 & 2034
  • Figure 32: Asia Pacific Standard Pen Needles Market Value Share (%), by Needle Size, 2025
  • Figure 33: Asia Pacific Standard Pen Needles Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 34: Asia Pacific Standard Pen Needles Market Value Share (%), by Distribution Channel, 2025
  • Figure 35: Asia Pacific Standard Pen Needles Market Value (USD billion), By Country/Sub-region, 2025 & 2034
  • Figure 36: Asia Pacific Standard Pen Needles Market Value Share (%), By Country/Sub-region, 2025
  • Figure 37: Latin America Standard Pen Needles Market Value (USD billion), by Drug Type, 2025 & 2034
  • Figure 38: Latin America Standard Pen Needles Market Value Share (%), by Drug Type, 2025
  • Figure 39: Latin America Standard Pen Needles Market Value (USD billion), by Disease Indication, 2025 & 2034
  • Figure 40: Latin America Standard Pen Needles Market Value Share (%), by Disease Indication, 2025
  • Figure 41: Latin America Standard Pen Needles Market Value (USD billion), by Needle Size, 2025 & 2034
  • Figure 42: Latin America Standard Pen Needles Market Value Share (%), by Needle Size, 2025
  • Figure 43: Latin America Standard Pen Needles Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 44: Latin America Standard Pen Needles Market Value Share (%), by Distribution Channel, 2025
  • Figure 45: Latin America Standard Pen Needles Market Value (USD billion), By Country/Sub-region, 2025 & 2034
  • Figure 46: Latin America Standard Pen Needles Market Value Share (%), By Country/Sub-region, 2025
  • Figure 47: Middle East & Africa Standard Pen Needles Market Value (USD billion), by Drug Type, 2025 & 2034
  • Figure 48: Middle East & Africa Standard Pen Needles Market Value Share (%), by Drug Type, 2025
  • Figure 49: Middle East & Africa Standard Pen Needles Market Value (USD billion), by Disease Indication, 2025 & 2034
  • Figure 50: Middle East & Africa Standard Pen Needles Market Value Share (%), by Disease Indication, 2025
  • Figure 51: Middle East & Africa Standard Pen Needles Market Value (USD billion), by Needle Size, 2025 & 2034
  • Figure 52: Middle East & Africa Standard Pen Needles Market Value Share (%), by Needle Size, 2025
  • Figure 53: Middle East & Africa Standard Pen Needles Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 54: Middle East & Africa Standard Pen Needles Market Value Share (%), by Distribution Channel, 2025
  • Figure 55: Middle East & Africa Standard Pen Needles Market Value (USD billion), By Country/Sub-region, 2025 & 2034
  • Figure 56: Middle East & Africa Standard Pen Needles Market Value Share (%), By Country/Sub-region, 2025
  • Figure 57: Global Standard Pen Needles Market Share (%), 2025